BCX 4430 3022 19992-50-8

19992-50-8

CHR-2797 is converted into a pharmacologically active acid product (CHR-79888) inside cells

Epetraborole was in development for the treatment of infections caused by multidrug-resistant Gram-negative pathogens

which as client proteins depend on functional HsP90 for maintenance

In platelet physiological responses

BCX 4430 3022 19992-50-8Galidesivir, also known as BCX4430 and Immucillin A, is an antiviral drug and an adenosine analog. Galidesivir was originally intended as a treatment for Hepatitis C, but subsequently developed as a potential treatment for deadly filovirus infections such as Ebola virus disease and Marburg virus disease. Galidesivir also shows broad spectrum antiviral effectiveness against a range of other RNA virus families, including bunyaviruses, arenaviruses,